Product Information
QC DUAL ACTION PAIN 250-125 MG is a generic product labeled by Chain Drug Marketing Association, priced at $0.1058 per EA under NDC 83324014936. Its NADAC has been published 90 times since Dec 4, 2024.
FDA first approved this application on Aug 1, 2023.
Strength
250; 125 mg/1; mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
83324014936
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA216999FDA Approved
8/1/2023
On Market Since
10/3/2024
Pharmacological Classes
Price Statistics
The NADAC for QC DUAL ACTION PAIN 250-125 MG has been published 90 times since Dec 4, 2024, and over the history we have for it it has risen 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1086 (Jul 16, 2025) |
| All-time low | $0.0839 (Apr 22, 2026) |
| 52-week high | $0.1058 |
| 52-week low | $0.0839 |
| Median price | $0.0906 |
| Average price | $0.0922 |
| Largest weekly change | +11.7% (May 21, 2025) |
| Weeks tracked | 90 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QC DUAL ACTION PAIN 250-125 MG?
The current National Average Drug Acquisition Cost (NADAC) for QC DUAL ACTION PAIN 250-125 MG, manufactured by Chain Drug Marketing Association, is $0.1058 per EA (NDC 83324014936), effective Aug 19, 2026.
How has the price of QC DUAL ACTION PAIN 250-125 MG changed over time?
Over the history we have for it, the NADAC for QC DUAL ACTION PAIN 250-125 MG has risen 25.9%. It has been tracked across 90 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for QC DUAL ACTION PAIN 250-125 MG?
Since Dec 4, 2024, the NADAC for QC DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0839 (Apr 22, 2026) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0906 per EA.
Are there cheaper alternatives to QC DUAL ACTION PAIN 250-125 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN-IBUPROFEN 250-125 MG CAPLET, is $0.0844 per EA — about 20% below QC DUAL ACTION PAIN 250-125 MG.
Who manufactures QC DUAL ACTION PAIN 250-125 MG?
QC DUAL ACTION PAIN 250-125 MG (NDC 83324014936) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.